Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Mol Immunol ; 43(9): 1293-315, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16213021

ABSTRACT

Surfactant proteins, SP-A and SP-D, are collagen-containing C-type (calcium dependent) lectins called collectins, which contribute significantly to surfactant homeostasis and pulmonary immunity. These highly versatile innate immune molecules are involved in a range of immune functions including viral neutralization, clearance of bacteria, fungi and apoptotic and necrotic cells, down regulation of allergic reaction and resolution of inflammation. Their basic structures include a triple-helical collagen region and a C-terminal homotrimeric lectin or carbohydrate recognition domain (CRD). The trimeric CRDs can recognize carbohydrate or charge patterns on microbes, allergens and dying cells, while the collagen region can interact with receptor molecules present on a variety of immune cells in order to initiate clearance mechanisms. Studies involving gene knock-out mice, murine models of lung hypersensitivity and infection, and functional characterization of cell surface receptors have revealed the diverse roles of SP-A and SP-D in the control of lung inflammation. A recently proposed model based on studies with the calreticulin-CD91 complex as a receptor for SP-A and SP-D has suggested an anti-inflammatory role for SP-A and SP-D in naïve lungs which would help minimise the potential damage that continual low level exposure to pathogens, allergens and apoptosis can cause. However, when the lungs are overwhelmed with exogenous insults, SP-A and SP-D can assume pro-inflammatory roles in order to complement pulmonary innate and adaptive immunity. This review is an update on the structural and functional aspects of SP-A and SP-D, with emphasis on their roles in controlling pulmonary infection, allergy and inflammation. We also try to put in perspective the controversial subject of the candidate receptor molecules for SP-A and SP-D.


Subject(s)
Pulmonary Surfactant-Associated Protein A/chemistry , Pulmonary Surfactant-Associated Protein A/physiology , Pulmonary Surfactant-Associated Protein D/chemistry , Pulmonary Surfactant-Associated Protein D/physiology , Allergens , Amino Acid Sequence , Amniotic Fluid/physiology , Animals , Bacteria/pathogenicity , Crystallography, X-Ray , Female , Fungi/pathogenicity , Humans , Lung/immunology , Lung/microbiology , Lung/physiology , Mice , Mice, Knockout , Models, Molecular , Molecular Sequence Data , Pregnancy , Pulmonary Surfactant-Associated Protein A/genetics , Pulmonary Surfactant-Associated Protein A/immunology , Pulmonary Surfactant-Associated Protein D/genetics , Pulmonary Surfactant-Associated Protein D/immunology , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/physiology , Receptors, Immunologic/chemistry , Receptors, Immunologic/physiology , Sequence Homology, Amino Acid , Viruses/pathogenicity , Yeasts/pathogenicity
2.
Arch Immunol Ther Exp (Warsz) ; 53(5): 399-417, 2005.
Article in English | MEDLINE | ID: mdl-16314824

ABSTRACT

Surfactant proteins A (SP-A) and D (SP-D) are lung surfactant-associated hydrophilic proteins that have been implicated in surfactant homeostasis and pulmonary innate immunity. They are collagen-containing C-type (calcium-dependent) lectins, called collectins, and are structurally similar to mannose-binding protein of the lectin pathway of the complement system. Being carbohydrate pattern-recognition molecules, they recognize a broad spectrum of pathogens and allergens via the lectin domain, with subsequent activation of immune cells via the collagen region, thus offering protection against infection and allergenic challenge. SP-A and SP-D have been shown to be involved in viral neutralization, clearance of bacteria, fungi, and apoptotic and necrotic cells, down-regulation of allergic reaction, and resolution of inflammation. Studies on single-nucleotide polymorphism, protein levels in broncho-alveolar lavage, and gene knock-out mice have clearly indicated an association between SP-A and SP-D and a range of pulmonary diseases. In addition, recent studies using murine models of allergy and infection have raised the possibility that the recombinant forms of SP-A and SP-D may have therapeutic potential in controlling pulmonary infection, inflammation, and allergies in humans.


Subject(s)
Pulmonary Surfactant-Associated Protein A/physiology , Pulmonary Surfactant-Associated Protein D/physiology , Animals , Asthma/etiology , Biomarkers , Bronchopulmonary Dysplasia/etiology , Female , Fetal Diseases/prevention & control , Humans , Hypersensitivity/etiology , Infant, Newborn , Lung/immunology , Lung/microbiology , Mice , Pregnancy , Pulmonary Surfactant-Associated Protein A/analysis , Pulmonary Surfactant-Associated Protein A/chemistry , Pulmonary Surfactant-Associated Protein A/genetics , Pulmonary Surfactant-Associated Protein D/analysis , Pulmonary Surfactant-Associated Protein D/chemistry , Pulmonary Surfactant-Associated Protein D/genetics , Respiratory Distress Syndrome/etiology , Tuberculosis, Pulmonary/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...